Brook, R. D. et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association.
Brook, R. D. et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association.
Brook RD, Rajagopalan S, Pope CA, 3rd, Brook JR, Bhatnagar A, Diez-Roux AV et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association.
Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez-Roux AV, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association.
According to recent update to the scientific statement from the American Heart Association (AHA), PM exposure can trigger acute cardiovascular events and accelerate chronic CVDs [ 8].
In the 2015 update to the position statement of the ADA regarding the management of T2DM, the use of agents that inhibit SGLT2 has been included as an option for dual therapy (in combination with metformin) or triple therapy (in combination with metformin plus a sulfonylurea, thiazolidinedione, dipeptidyl peptidase-4 inhibitor [DPP-4i], or insulin) [ 3].
The Standards for the Reporting of Diagnostic Accuracy (STARD) statement, which was recently updated to the STARD2015 statement, was developed to encourage complete and transparent reporting of test accuracy studies.
This story has been updated to include the statement from the U.S. attorney's office.
This article has been updated to include the statement's third author, Ray Weymann.
Updated December 11 , 2017 9 15pm EST: This article has been updated to include the statement from CFTC chairman J. Christopher Giancarlo.
